Table 4 Multivariable logistic regression analysis for predictors of early complications related to stoma and ureteroileal anastomosis in bladder cancer patients after ileal conduit surgery
From: An improved ileal conduit surgery for bladder cancer with fewer complications
Variable | Stoma-related complications | Ureteroileal anastomosis-related complications | ||
|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Ileal conduit surgery (modified vs. conventional) | 0.211 (0.027–0.689) | 0.020 | 0.314 (0.077–0.831) | 0.012 |
Age (> 62 vs. ≤ 62) | 0.036 (0.001–2.866) | 0.136 | 0.138 (0.008–3.499) | 0.281 |
Gender (female vs. male) | 5.949 (0.159–19.235) | 0.334 | 2.003 (0.412–9.753) | 0.390 |
Smoking (yes vs. no) | 0.740 (0.185–7.682) | 0.272 | 0.459 (0.114–1.847) | 0.273 |
CCI (> 2 vs. ≤ 2) | 2.643 (0.330–11.160) | 0.173 | 3.541 (0.977–12.831) | 0.054 |
ASA (> 2 vs. ≤ 2) | 1.445 (0.152–8.473) | 0.275 | 1.413 (0.292–6.852) | 0.248 |
Prior pelvic irradiation (yes vs. no) | 1.013 (0.183–6.592) | 0.562 | 1.256 (0.089–7.697) | 0.465 |
Preoperative hydronephrosis (yes vs. no) | 1.211 (0.228–6.592) | 0.352 | 2.069 (0.603–7.098) | 0.248 |
Pathologic T stage | ||||
 T2 vs. T1 | 1.893 (0.564–8.259) | 0.652 | 2.609 (0.376–10.119 | 0.332 |
 T3 vs. T2 | 2.351 (0.268–9.543) | 0.342 | 1.769 (0.669–8.629) | 0.231 |
 T4 vs. T3 | 1.367 (0.327–6.562) | 0.103 | 1.749 (0.594–7.540) | 0.308 |
Pathologic N stage (N + vs. N0) | 1.534 (0.351–10.265) | 0.065 | 1960 (0.219–13.560) | 0.125 |
Adjuvant chemotherapy (yes vs. no) | 1.125 (0.056–12.546) | 0.218 | 1.683 (0.852–7.007) | 0.172 |
BMI (> 21.8 vs. ≤ 21.8) | 1.879 (0.253–6.753) | 0.097 | 1.411 (0.406–4.906) | 0.189 |
Year of surgery (> 2009 vs. ≤ 2009) | 0.783 (0.073–2.126) | 0.348 | 0.401 (0.097–1.652) | 0.206 |